Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Wickenden

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Molecular Pharmacology|November 5, 2016
State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281Marie-Laure Rives, Morena Shaw, Bin Zhu, et al.
The Journal of Biological Chemistry|February 22, 2020
A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2)Kelly L Damm-Ganamet, Marie-Laure Rives, Alan D Wickenden, et al.
Future Medicinal Chemistry|March 24, 2011
Recent advances in the biology and medicinal chemistry of TRPA1Jason C Rech, William A Eckert, Michael P Maher, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2009
Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channelMichael F Gross, Neil A Castle, Anruo Zou, et al.
Combinatorial Chemistry & High Throughput Screening|January 20, 2009
HCN channels as targets for drug discoveryMichael P Maher, Nyan-Tsz Wu, Hong-Qing Guo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammoniumJennifer K Hadley, Gayle M Passmore, Lucine Tatulian, et al.
American Journal of Physiology. Cell Physiology|August 2, 2003
Distribution and functional properties of human KCNH8 (Elk1) potassium channelsAnruo Zou, Zhixin Lin, Margaret Humble, et al.
Molecular Pharmacology|January 4, 2008
Activation of TRPA1 by farnesyl thiosalicylic acidMichael Maher, Hong Ao, Tue Banke, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of EpilepsyGeorge Amato, Rosemarie Roeloffs, Greg C Rigdon, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2008
In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant modelsRosemarie Roeloffs, Alan D Wickenden, Christopher Crean, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Molecular Pharmacology|November 5, 2016
State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281Marie-Laure Rives, Morena Shaw, Bin Zhu, et al.
The Journal of Biological Chemistry|February 22, 2020
A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2)Kelly L Damm-Ganamet, Marie-Laure Rives, Alan D Wickenden, et al.
Future Medicinal Chemistry|March 24, 2011
Recent advances in the biology and medicinal chemistry of TRPA1Jason C Rech, William A Eckert, Michael P Maher, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2009
Aryl sulfonamido tetralin inhibitors of the Kv1.5 ion channelMichael F Gross, Neil A Castle, Anruo Zou, et al.
Combinatorial Chemistry & High Throughput Screening|January 20, 2009
HCN channels as targets for drug discoveryMichael P Maher, Nyan-Tsz Wu, Hong-Qing Guo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2003
Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammoniumJennifer K Hadley, Gayle M Passmore, Lucine Tatulian, et al.
American Journal of Physiology. Cell Physiology|August 2, 2003
Distribution and functional properties of human KCNH8 (Elk1) potassium channelsAnruo Zou, Zhixin Lin, Margaret Humble, et al.
Molecular Pharmacology|January 4, 2008
Activation of TRPA1 by farnesyl thiosalicylic acidMichael Maher, Hong Ao, Tue Banke, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of EpilepsyGeorge Amato, Rosemarie Roeloffs, Greg C Rigdon, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2008
In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant modelsRosemarie Roeloffs, Alan D Wickenden, Christopher Crean, et al.
Pageof 5